Company profile for Phathom Pharmaceuticals

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Phathom Pharmaceuticals is a late clinical-stage biopharmaceutical company committed to transforming the treatment landscape for people suffering from gastrointestinal (GI) diseases related to acid. Our initial product candidate, vonoprazan, is a potassium competitive acid blocker (P-CAB), a new class of anti-secretory medicines with potential applications in GI diseases.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
2150 E. Lake Cook Road, Suite 800 Buffalo Grove, Illinois 60089
Telephone
Telephone
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

BePharma

Not Confirmed

envelop Contact Supplier

BePharma

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2026/02/23/3242577/0/en/Phathom-Pharmaceuticals-to-Participate-in-Upcoming-Investor-Conferences.html

GLOBENEWSWIRE
23 Feb 2026

https://www.globenewswire.com/news-release/2026/02/17/3239216/0/en/Phathom-Pharmaceuticals-to-Report-Fourth-Quarter-and-Full-Year-2025-Financial-Results-and-Provide-Business-Update-on-Thursday-February-26-2026.html

GLOBENEWSWIRE
17 Feb 2026

https://www.globenewswire.com/news-release/2026/02/05/3232957/0/en/Phathom-Pharmaceuticals-to-Present-at-the-Guggenheim-Emerging-Outlook-Biotech-Summit-2026.html

GLOBENEWSWIRE
05 Feb 2026

https://www.globenewswire.com/news-release/2026/01/07/3214891/0/en/Phathom-Pharmaceuticals-Announces-Preliminary-Fourth-Quarter-and-Full-Year-2025-Financial-Results.html

GLOBENEWSWIRE
07 Jan 2026

https://www.globenewswire.com/news-release/2026/01/07/3214899/0/en/Phathom-Pharmaceuticals-Announces-Proposed-Public-Offering-of-Common-Stock-and-Pre-Funded-Warrants.html

GLOBENEWSWIRE
07 Jan 2026

https://www.globenewswire.com/news-release/2025/11/04/3180287/0/en/Phathom-Pharmaceuticals-Announces-First-Patient-Dosed-in-Phase-2-Study-of-VOQUEZNA-vonoprazan-in-Eosinophilic-Esophagitis-EoE.html

GLOBENEWSWIRE
04 Nov 2025

FDA Orange Book

read-more
read-more

01

Brand Name : VOQUEZNA TRIPLE PAK

BePharma
Not Confirmed
arrow

Brand Name : VOQUEZNA TRIPLE PAK

BePharma
Not Confirmed
arrow

Phathom Pharmaceuticals

Dosage Form : CAPSULE, TABLET, TABLET; ORAL

Proprietary Name : VOQUEZNA TRIPLE PAK

Dosage Strength : 500MG;500MG;EQ 20MG BASE

Approval Date : 2022-05-03

Application Number : 215152

RX/OTC/DISCN : RX

RLD : Yes

TE Code :

blank

02

Brand Name : VOQUEZNA DUAL PAK

BePharma
Not Confirmed
arrow

Brand Name : VOQUEZNA DUAL PAK

BePharma
Not Confirmed
arrow

Phathom Pharmaceuticals

Dosage Form : CAPSULE, TABLET; ORAL

Proprietary Name : VOQUEZNA DUAL PAK

Dosage Strength : 500MG;EQ 20MG BASE

Approval Date : 2022-05-03

Application Number : 215153

RX/OTC/DISCN : RX

RLD : Yes

TE Code :

blank

03

Brand Name : VOQUEZNA

BePharma
Not Confirmed
arrow

Brand Name : VOQUEZNA

BePharma
Not Confirmed
arrow

Phathom Pharmaceuticals

Dosage Form : TABLET; ORAL

Proprietary Name : VOQUEZNA

Dosage Strength : EQ 10MG BASE

Approval Date : 2023-11-01

Application Number : 215151

RX/OTC/DISCN : RX

RLD : Yes

TE Code :

blank

04

Brand Name : VOQUEZNA

BePharma
Not Confirmed
arrow

Brand Name : VOQUEZNA

BePharma
Not Confirmed
arrow

Phathom Pharmaceuticals

Dosage Form : TABLET; ORAL

Proprietary Name : VOQUEZNA

Dosage Strength : EQ 20MG BASE

Approval Date : 2023-11-01

Application Number : 215151

RX/OTC/DISCN : RX

RLD : Yes

TE Code :

blank

05

Brand Name : VOQUEZNA

BePharma
Not Confirmed
arrow

Brand Name : VOQUEZNA

BePharma
Not Confirmed
arrow

Phathom Pharmaceuticals

Dosage Form : TABLET; ORAL

Proprietary Name : VOQUEZNA

Dosage Strength : EQ 10MG BASE

Approval Date :

Application Number : 218710

RX/OTC/DISCN :

RLD :

TE Code :

blank

06

Brand Name : VOQUEZNA

BePharma
Not Confirmed
arrow

Brand Name : VOQUEZNA

BePharma
Not Confirmed
arrow

Phathom Pharmaceuticals

Dosage Form : TABLET; ORAL

Proprietary Name : VOQUEZNA

Dosage Strength : EQ 20MG BASE

Approval Date :

Application Number : 218710

RX/OTC/DISCN :

RLD :

TE Code :

blank

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty